Dehydroepiandrosterone, Serum or Plasma
Ordering Recommendation
Adjunct test for the investigation of hyperandrogenic and adrenal disorders. Not recommended for initial evaluation of polycystic ovarian syndrome.
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
1-4 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
Collect between 6-10 a.m.  
Serum separator tube or green (sodium or lithium heparin). Also acceptable: Lavender (EDTA).  
Specimen Preparation
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)  
Storage/Transport Temperature
Unacceptable Conditions
After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months  
Reference Interval
Effective August 19, 2013
Age Female Male
Premature Less than 40 ng/mL Less than 40 ng/mL
0-​1 day Less than 11 ng/mL Less than 11 ng/mL
2-​6 days Less than 8.7 ng/mL Less than 8.7 ng/mL
7 days-​1 month Less than 5.8 ng/mL Less than 5.8 ng/mL
1-​5 months Less than 2.9 ng/mL Less than 2.9 ng/mL
6-​24 months Less than 1.9 9 ng/mL Less than 2.5 ng/mL
2-​3 years Less than 0.85 ng/mL Less than 0.63 ng/mL
4-​5 years Less than 1.03 ng/mL Less than 0.95 ng/mL
6-​7 years Less than 1.79 ng/mL 0.06-​1.93 ng/mL
8-​9 years 0.14-​2.35 ng/mL 0.10-​2.08 ng/mL
10-​11 years 0.43-​3.78 ng/mL 0.32-​3.08 ng/mL
12-​13 years 0.89-​6.21 ng/mL 0.57-​4.10 ng/mL
14-​15 years 1.22-​7.01 ng/mL 0.93-​6.04 ng/mL
16-​17 years 1.42-​9.00 ng/mL 1.17-​6.52 ng/mL
18-​39 years 1.33-​7.78 ng/mL 1.33-​7.78 ng/mL
40 years and older 0.63-​4.70 ng/mL 0.63-​4.70 ng/mL
Postmenopausal 0.60-​5.73 ng/mL Does Not Apply
Tanner Stage I 0.14-​2.76 ng/mL 0.11-​2.37 ng/mL
Tanner Stage II 0.83-​4.87 ng/mL 0.37-​3.66 ng/mL
Tanner Stage III 1.08-​7.56 ng/mL 0.75-​5.24 ng/mL
Tanner Stage IV-​V 1.24-​7.88 ng/mL 1.22-​6.73 ng/mL
Interpretive Data

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
CPT Code(s)
Component Test Code*Component Chart NameLOINC
2001641Dehydroepiandrosterone by TMS2193-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • DHEA (Dehydroepiandrosterone, Serum or Plasma)
  • Unconjugated DHEA (Dehydroepiandrosterone, Serum or Plasma)